K-V Pharma (KV-A) Files 9.95M Common Shelf for Selling Stockholders
Tweet
Share
E-mail
K-V Pharmaceutical (NYSE: KV-A) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 9.95 million shares of common stock on behalf of selling stockholders.
K-V Pharma will not receive proceeds from the offering.
K-V Pharma will not receive proceeds from the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- enVVeno Medical (NVNO) files $100M mixed shelf
- Global Interactive Technologies receives Nasdaq non-compliance notice
- Jupiter Neurosciences prices $2M registered direct offering of shares
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
